RAB5C expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.320200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.788200E-01
Normal-vs-Stage2
5.887600E-01
Normal-vs-Stage3
2.144800E-01
Normal-vs-Stage4
7.591600E-01
Stage1-vs-Stage2
6.527400E-01
Stage1-vs-Stage3
2.924200E-01
Stage1-vs-Stage4
7.007500E-02
Stage2-vs-Stage3
1.478780E-01
Stage2-vs-Stage4
3.502400E-01
Stage3-vs-Stage4
8.277600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.926800E-01
Normal-vs-AfricanAmerican
8.861000E-01
Normal-vs-Asian
4.497400E-01
Caucasian-vs-AfricanAmerican
2.382600E-01
Caucasian-vs-Asian
6.266400E-01
AfricanAmerican-vs-Asian
2.452000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.287800E-01
Normal-vs-Female
5.440600E-01
Male-vs-Female
6.554000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.178200E-01
Normal-vs-Age(41-60Yrs)
8.747600E-01
Normal-vs-Age(61-80Yrs)
4.317400E-01
Normal-vs-Age(81-100Yrs)
3.323600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.197400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.644400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.423800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.715800E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.025250E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.518600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.988200E-01
Normal-vs-Daily Drinker
2.195600E-01
Normal-vs-Weekly Drinker
6.544400E-01
Normal-vs-Occasional Drinker
9.767200E-01
Normal-vs-Social Drinker
4.676400E-01
Non Drinker-vs-Daily Drinker
7.350000E-01
Non Drinker-vs-Weekly Drinker
4.217200E-01
Non Drinker-vs-Occasional Drinker
4.130400E-02
Non Drinker-vs-Social Drinker
3.463200E-01
Daily Drinker-vs-Weekly Drinker
2.323400E-01
Daily Drinker-vs-Occasional Drinker
1.376380E-02
Daily Drinker-vs-Social Drinker
1.910560E-01
Weekly Drinker-vs-Occasional Drinker
3.767000E-01
Weekly Drinker-vs-Social Drinker
9.223800E-01
Occasional Drinker-vs-Social Drinker
2.143200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.374600E-01
Normal-vs-Grade 2
6.136800E-01
Normal-vs-Grade 3
6.204200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.443840E-02
Grade 1-vs-Grade 3
3.696200E-02
Grade 1-vs-Grade 4
7.374600E-01
Grade 2-vs-Grade 3
8.551400E-01
Grade 2-vs-Grade 4
6.136800E-01
Grade 3-vs-Grade 4
6.204200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.733800E-01
Normal-vs-NonDiabetic
5.013400E-01
Diabetic-vs-NonDiabetic
6.169800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.471400E-01
Normal-vs-NoPancreatitis
5.086000E-01
Pancreatitis-vs-NoPancreatitis
4.317800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.693600E-01
Normal-vs-N1
5.922200E-01
N0-vs-N1
5.302400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.355400E-01
Normal-vs-TP53-NonMutant
2.250200E-01
TP53-Mutant-vs-TP53-NonMutant
7.556400E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
